Hall Ryan Renaldo, Cohall Damian Hugh
Faculty of Medical Sciences, University of the West Indies, Cave Hill, Barbados.
Med Cannabis Cannabinoids. 2024 May 22;7(1):91-98. doi: 10.1159/000538297. eCollection 2024 Jan-Dec.
Of the seventy million people who suffer from epilepsy, 40 percent of them become resistant to more than one antiepileptic medication and have a higher chance of death. While the classical definition of epilepsy was due to the imbalance between excitatory glutamatergic and inhibitory γ-aminobutyric acid (GABA)-ergic signalling, substantial evidence implicates muscarinic receptors in the regulation of neural excitability.
Cannabinoids have shown to reduce seizure activity and neuronal excitability in several epileptic models through the activation of muscarinic receptors with drugs which modulate their activity. Cannabinoids also have been effective in reducing antiepileptic activity in pharmaco-resistant individuals; however, the mechanism of its effects in temporal lobe epilepsy is not clear.
This review seeks to elucidate the relationship between muscarinic and cannabinoid receptors in epilepsy and neural excitability.
在七千万癫痫患者中,40%的患者对不止一种抗癫痫药物产生耐药性,且死亡几率更高。虽然癫痫的经典定义是由于兴奋性谷氨酸能和抑制性γ-氨基丁酸(GABA)能信号之间的失衡,但大量证据表明毒蕈碱受体参与神经兴奋性的调节。
在几种癫痫模型中,大麻素已显示出通过用调节其活性的药物激活毒蕈碱受体来降低癫痫发作活动和神经元兴奋性。大麻素在耐药个体中也有效降低抗癫痫活性;然而,其在颞叶癫痫中的作用机制尚不清楚。
本综述旨在阐明癫痫中毒蕈碱受体与大麻素受体之间的关系以及神经兴奋性。